Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
Continued strong patient recruitment in neuroendocrine tumors for lead program VMT-α-NET sets the stage for submissions of robust clinical data ...
BCS set out to design and build high-performance cyclotrons, establishing expertise in cyclotrons ranging from 1 MeV to 70 MeV and beyond. Its vision was to advance global healthcare by delivering ...
Cyclotrons have fundamentally transformed nuclear medicine and cancer therapy over the past decade, with major milestones ...
Cyclotrons have fundamentally transformed nuclear medicine and cancer therapy over the past decade, with major milestones driven by Best ABT, Best Cyclotron Systems (BCS) and TeamBest Global (TBG), un ...
Purpose-built facility secures Convergent's drug product manufacturing at the scale needed to meet late-stage CONV01- clinical studies and commercial demand Expanded partnership designed to drive ...
An update from Alpha Tau Medical Ltd ( (DRTS)) is now available. On January 5, 2026, Alpha Tau Medical announced it has submitted the first module of its pre-market approval application to the U.S.
Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...
The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Myqorzo (aficamten, Cytokinetics) for treating adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback